The lab of David E Reich at Harvard Medical School focuses on utilizing ancient DNA to enhance our understanding of human genetic traits and disease risk over time. By analyzing large datasets from various historical populations, the lab aims to uncover how evolutionary forces have shaped genetic variation and complex traits in humans. This research not only provides insights into our past but also helps make connections to present-day health issues and genetic diversity.

Dr. Gokhan Hotamisligil's research focuses on understanding the role of a newly identified hormone complex named Fabkin in the context of atherosclerosis, a leading cause of cardiovascular diseases. The lab investigates how this complex influences lipid metabolism and inflammation, aiming to discover novel therapeutic strategies to improve current treatments for these conditions. Through animal studies and cellular experiments, the team seeks to unravel the mechanisms behind dyslipidemia and its contribution to heart disease.

Dr. Scott G. Kennedy's lab at Harvard Medical School focuses on understanding the role of non-coding RNAs in gene regulation and inheritance. The research primarily uses the C. elegans model to investigate how these molecules influence gene expression and contribute to the transmission of epigenetic information across generations. This work aims to uncover the mechanisms behind epigenetic processes that could be linked to various human diseases.

The Manning lab at Harvard focuses on understanding how certain signaling pathways in cells become malfunctioning in cancer, specifically the PI3K and mTOR pathways. They investigate the mechanisms behind tumor growth and how cancer cells adapt their metabolism to thrive. The lab uses innovative genetic mouse models and advanced methodologies to reveal new ways to target these cancer pathways, aiming to develop novel cancer therapies.

Dr. Kamila Naxerova's lab at Harvard Medical School studies how cancer spreads, particularly focusing on colorectal cancer that metastasizes to the peritoneum. They are investigating the origins of these tumors, how different cancer cells invade the peritoneal cavity, and the genetic factors that affect patient survival. Through their research, they aim to improve treatment options for patients with this serious condition, shedding light on the genetic mechanisms behind cancer metastasis.

Dr. Norbert Perrimon's lab at Harvard Medical School focuses on understanding critical biological processes through the study of Drosophila, a model organism. The ongoing research explores immune signaling in ticks to improve our knowledge of tick-borne diseases, molecular mechanisms of muscle growth and wasting to address health issues like sarcopenia, and the communication between different organs as they age. By leveraging advanced technologies, the lab aims to uncover fundamental biological pathways relevant to human health.

Dr. Bruce Yankner's lab focuses on understanding how the REST transcription factor influences brain function and microglial health, particularly in the context of Alzheimer's disease. They explore the mechanisms behind memory loss and neuroinflammation, aiming to develop new therapeutic strategies that could protect neurons and improve cognitive function in aging populations. Their research combines innovative mouse models, advanced molecular techniques, and drug discovery to offer insights that could lead to better treatments for Alzheimer's disease.